Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fulvio Mavilio

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Hematology/Oncology Clinics of North America|September 13, 2017
Gene Therapy Approaches to HemoglobinopathiesGiuliana Ferrari, Marina Cavazzana, Fulvio Mavilio
Human Gene Therapy|January 22, 2013
Mechanisms of retroviral integration and mutagenesisAlessia Cavazza, Arianna Moiani, Fulvio Mavilio
Clinics in Dermatology|July 19, 2005
Gene therapy approaches for epidermolysis bullosaStefano Ferrari, Graziella Pellegrini, Fulvio Mavilio, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 26, 2005
T Lymphocytes transduced with a lentiviral vector expressing F12-Vif are protected from HIV-1 infection in an APOBEC3G-independent mannerGiuliana Vallanti, Rossella Lupo, Maurizio Federico, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2004
Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectorsAlessandra Recchia, Laura Perani, Daniela Sartori, et al.
Expert Opinion on Biological Therapy|March 22, 2006
Gene therapy in combination with tissue engineering to treat epidermolysis bullosaStefano Ferrari, Graziella Pellegrini, Tatsuya Matsui, et al.
Reviews on Recent Clinical Trials|May 14, 2008
Towards a gene therapy clinical trial for epidermolysis bullosaStefano Ferrari, Graziella Pellegrini, Tatsuya Matsui, et al.
Molecular Therapy. Nucleic Acids|September 10, 2018
Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR/Cas9 and Homology-Directed RepairAraksya Izmiryan, Clarisse Ganier, Matteo Bovolenta, et al.
Plos One|December 14, 2011
The GATA1-HS2 enhancer allows persistent and position-independent expression of a β-globin transgeneAnnarita Miccio, Valentina Poletti, Francesca Tiboni, et al.
Human Gene Therapy|May 27, 2005
Competitive engraftment of hematopoietic stem cells genetically modified with a truncated erythropoietin receptorFabrizia Urbinati, Francesco Lotti, Giulia Facchini, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Hematology/Oncology Clinics of North America|September 13, 2017
Gene Therapy Approaches to HemoglobinopathiesGiuliana Ferrari, Marina Cavazzana, Fulvio Mavilio
Human Gene Therapy|January 22, 2013
Mechanisms of retroviral integration and mutagenesisAlessia Cavazza, Arianna Moiani, Fulvio Mavilio
Clinics in Dermatology|July 19, 2005
Gene therapy approaches for epidermolysis bullosaStefano Ferrari, Graziella Pellegrini, Fulvio Mavilio, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 26, 2005
T Lymphocytes transduced with a lentiviral vector expressing F12-Vif are protected from HIV-1 infection in an APOBEC3G-independent mannerGiuliana Vallanti, Rossella Lupo, Maurizio Federico, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2004
Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectorsAlessandra Recchia, Laura Perani, Daniela Sartori, et al.
Expert Opinion on Biological Therapy|March 22, 2006
Gene therapy in combination with tissue engineering to treat epidermolysis bullosaStefano Ferrari, Graziella Pellegrini, Tatsuya Matsui, et al.
Reviews on Recent Clinical Trials|May 14, 2008
Towards a gene therapy clinical trial for epidermolysis bullosaStefano Ferrari, Graziella Pellegrini, Tatsuya Matsui, et al.
Molecular Therapy. Nucleic Acids|September 10, 2018
Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR/Cas9 and Homology-Directed RepairAraksya Izmiryan, Clarisse Ganier, Matteo Bovolenta, et al.
Plos One|December 14, 2011
The GATA1-HS2 enhancer allows persistent and position-independent expression of a β-globin transgeneAnnarita Miccio, Valentina Poletti, Francesca Tiboni, et al.
Human Gene Therapy|May 27, 2005
Competitive engraftment of hematopoietic stem cells genetically modified with a truncated erythropoietin receptorFabrizia Urbinati, Francesco Lotti, Giulia Facchini, et al.
Pageof 9